Cargando…
Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
Dialysis patients are more likely to die or become hospitalized from coronavirus disease 2019 (COVID-19). Currently, only a few studies have evaluated the efficacy of a fourth booster vaccination in hemodialysis (HD) patients and there is not enough evidence to recommend for or against a fourth boos...
Autores principales: | Joo, Yoosun, Kim, Dae Kyu, Jeon, Yun Gi, Kim, Ah-Ra, Do, Hyeon Nam, Yoon, Soo-Young, Kim, Jin Sug, Jung, Su Woong, Hwang, Hyeon Seok, Moon, Ju-Young, Jeong, Kyung Hwang, Lee, Sang-Ho, Kang, So-Young, Kim, Yang Gyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610999/ https://www.ncbi.nlm.nih.gov/pubmed/37896987 http://dx.doi.org/10.3390/vaccines11101584 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis
por: Kim, Dae Kyu, et al.
Publicado: (2022) -
Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
por: Kim, Dae Kyu, et al.
Publicado: (2021) -
Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023) -
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020) -
Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients
por: Lee, Yu Ho, et al.
Publicado: (2020)